title: New Topical Therapeutic Options in the Management of Superficial Fungal Infections.
abstract: Dermatophyte infections of the skin and nails are common in the United States. These infections warrant treatment because they are symptomatic and progressive, and can predispose patients to superinfections. Topical drugs such as luliconazole, naftifine, efinaconazole, and tavaborole are newer options for treating these dermatophyte infections with proven safety, efficacy, and ease of use.
authors.forename: Joshua A
authors.initials: JA
authors.lastname: Zeichner
mesh_terms: D000891:Anti-Infective Agents, Local / Q000008:administration & dosage* / Q000009:adverse effects / Q000627:therapeutic use*; D000935:Antifungal Agents / Q000008:administration & dosage* / Q000009:adverse effects / Q000627:therapeutic use*; D003881:Dermatomycoses / Q000188:drug therapy* / Q000382:microbiology; D006801:Humans; D009262:Nails / Q000382:microbiology; D015163:Superinfection / Q000517:prevention & control
chemical_list: D000891:Anti-Infective Agents, Local; D000935:Antifungal Agents